{"id":"https://openalex.org/W2954953528","doi":"https://doi.org/10.1158/1538-7445.am2019-5029","title":"Abstract 5029: OT-101/Chemotherapy- A novel mechanism of action (MOA) in glioblastoma immunization therapy","display_name":"Abstract 5029: OT-101/Chemotherapy- A novel mechanism of action (MOA) in glioblastoma immunization therapy","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W2954953528","doi":"https://doi.org/10.1158/1538-7445.am2019-5029","mag":"2954953528"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2019-5029","doi":"https://doi.org/10.1158/1538-7445.am2019-5029","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-5029","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110557250","display_name":"Larn Hwang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Larn Hwang","raw_affiliation_strings":["Oncotelic Inc, Agoura Hills, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncotelic Inc, Agoura Hills, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072481595","display_name":"David Nam","orcid":"https://orcid.org/0000-0002-4650-5691","observed_orcids":["https://orcid.org/0000-0002-4650-5691"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Nam","raw_affiliation_strings":["Oncotelic Inc, Agoura Hills, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncotelic Inc, Agoura Hills, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091381226","display_name":"Fatih Mehmet Uckun","orcid":"https://orcid.org/0000-0001-9334-183X","observed_orcids":["https://orcid.org/0000-0001-9334-183X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fatih Uckun","raw_affiliation_strings":["Oncotelic Inc, Agoura Hills, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncotelic Inc, Agoura Hills, CA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059615305","display_name":"Vuong N. Trieu","orcid":"https://orcid.org/0000-0002-6675-0811","observed_orcids":["https://orcid.org/0000-0002-6675-0811"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vuong Trieu","raw_affiliation_strings":["Oncotelic Inc, Agoura Hills, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncotelic Inc, Agoura Hills, CA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"79","issue":"13_Supplement","first_page":"5029","last_page":"5029"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phosphorothioate-antisense-oligonucleotides","display_name":"phosphorothioate antisense oligonucleotides","score":0.8949999809265137},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.8700000047683716},{"id":"https://openalex.org/keywords/recurrent-high-grade-glioma","display_name":"recurrent high-grade glioma","score":0.8650000095367432},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.9269999861717224},{"id":"https://openalex.org/keywords/intratumoral-chemotherapy","display_name":"intratumoral chemotherapy","score":0.6470000147819519},{"id":"https://openalex.org/keywords/intratumor-heterogeneity","display_name":"intratumoral heterogeneity","score":0.6819999814033508},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5860000252723694},{"id":"https://openalex.org/keywords/microperfusion","display_name":"microperfusion","score":0.5529999732971191},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.6499999761581421},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.5239999890327454}],"concepts":[{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.9331094026565552},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.835901141166687},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7179650664329529},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5658589601516724},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.5434056520462036},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.49368390440940857},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.46013277769088745},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4312061667442322},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39358168840408325},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.10480976104736328}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2019-5029","doi":"https://doi.org/10.1158/1538-7445.am2019-5029","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-5029","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2960483874","https://openalex.org/W4388588521","https://openalex.org/W2986172884","https://openalex.org/W2989877647","https://openalex.org/W2057714372","https://openalex.org/W1987480128","https://openalex.org/W2789732873","https://openalex.org/W2947315175","https://openalex.org/W2089699323","https://openalex.org/W2955663607"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Escalating":[2],"Intratumoral":[3],"heterogeneity":[4],"(IH)":[5],"resulting":[6],"in":[7,45,102,130,138,148,154,199,282],"xenogenization":[8,60,72,262],"which":[9],"is":[10,17,81],"countered":[11],"by":[12,233,243,263],"overexpression":[13],"of":[14,27,40,57,62,71,100,125,152,160,167,197,251,255,279,289],"TGF-\u03b22.":[15],"OT-101":[16,41,101,132,143,205,244],"a":[18,28,82,116],"TGF-\u03b22-specific":[19],"Phosphorothioate":[20],"Antisense.":[21],"Here":[22],"we":[23],"report":[24],"the":[25,36,58,69,96,131,139,150,155,200,248,290],"results":[26],"randomized":[29,89],"Phase":[30],"2b":[31],"clinical":[32],"trial":[33],"(NCT00431561)":[34],"comparing":[35],"safety":[37,99],"and":[38,98,135,209,215,245,260],"efficacy":[39,97],"versus":[42,206],"temozolomide":[43,140],"(TMZ)":[44,141],"adult":[46,103],"patients":[47,104,129,137],"with":[48,77,105,172,204,212,222,247],"WHO":[49],"grade":[50],"III/IV":[51],"high-grade":[52,107],"glioma.":[53],"We":[54],"took":[55],"advantage":[56],"known":[59],"activity":[61],"alkylating":[63,181],"agent":[64],"such":[65],"TMZ":[66,147,173,178,223],"to":[67,94,146,236],"explore":[68],"impact":[70],"on":[73,75],"survival":[74,157,230],"treatment":[76],"OT-101.":[78],"Methods:":[79],"This":[80,239],"phase":[83],"2b,":[84],"multi-national,":[85],"multi-center,":[86],"open-label,":[87],"active-controlled,":[88],"parallel":[90],"group":[91,134],"dose-finding":[92],"study":[93],"evaluate":[95],"recurrent":[106],"glioma,":[108],"administered":[109],"intratumorally":[110],"as":[111,253],"continuous":[112],"high-flow":[113],"microperfusion":[114],"over":[115],"7-day":[117],"period":[118],"every":[119],"other":[120,180],"week.":[121],"Results:":[122],"A":[123,276],"total":[124],"134":[126],"patients,":[127],"89":[128],"test":[133],"45":[136,168,219],"group.":[142],"was":[144,231,240],"superior":[145],"doubling":[149],"number":[151],"pts":[153,162,169,202,211,220],"good":[156],"group,":[158],"64":[159],"97":[161],"(66%);":[163],"whereas,":[164],"only":[165],"14":[166],"(31%)":[170],"treated":[171,203,221],"did":[174],"(p=0.0001).":[175],"mOSOT-101TMZSubseq.":[176],"TMZSubseq.":[177],"(or":[179],"agent)Prev.":[182],"TMZNoYesNoYesNo4.2mos":[183],"(N=14)26.2mos":[184],"(N=30)5.6mos":[185],"(N=8)13.2mos":[186],"(N=9)Yes4.8mos":[187],"(N=19)29.5mos":[188],"(N=34)6.6mos":[189],"(N=14)36.6":[190],"mos":[191],"(N=14)":[192],"There":[193],"were":[194],"two":[195],"cases":[196],"neutropenia":[198],"90":[201],"8,":[207],"10,":[208],"8":[210],"leukopenia,":[213],"neutropenia,":[214],"thrombocytopenia,":[216],"respectively,":[217],"among":[218],"(2%":[224],"vs.":[225],"56%,":[226],"p<0.0001).":[227],"Conclusions:":[228],"Improved":[229],"achieved":[232],"repeated":[234],"exposure":[235],"TMZ/alkylating":[237],"agent.":[238],"further":[241],"enhanced":[242],"consistent":[246],"proposed":[249],"MOA":[250],"OT-101/Chemo":[252],"reactivation":[254],"immunity":[256],"during":[257],"TGF-\u03b2":[258],"suppression":[259],"subsequent":[261],"TMZ.":[264],"Citation":[265],"Format:":[266],"Larn":[267],"Hwang,":[268],"David":[269],"Nam,":[270],"Fatih":[271],"Uckun,":[272],"Vuong":[273],"Trieu.":[274],"OT-101/Chemotherapy-":[275],"novel":[277],"mechanism":[278],"action":[280],"(MOA)":[281],"glioblastoma":[283],"immunization":[284],"therapy":[285],"[abstract].":[286],"In:":[287],"Proceedings":[288],"American":[291],"Association":[292],"for":[293],"Cancer":[294,308],"Research":[295],"Annual":[296],"Meeting":[297],"2019;":[298],"2019":[299],"Mar":[300],"29-Apr":[301],"3;":[302],"Atlanta,":[303],"GA.":[304],"Philadelphia":[305],"(PA):":[306],"AACR;":[307],"Res":[309],"2019;79(13":[310],"Suppl):Abstract":[311],"nr":[312],"5029.":[313]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-07-12T00:00:00"}